Study Stopped
Deadline of the end date of the inclusions
Study of Functional Networks in Resting fMRI
DEPIMAGE
1 other identifier
interventional
37
0 countries
N/A
Brief Summary
The primary purpose is to compare with resting fMRI the functional networks of rest (RTS) in unipolar depression and in bipolar depression. Hypothesis : the main objective of this work is to compare with the rest fMRI the Rest Functional Networks (RFN) in the unipolar depression and in the bipolar depression in order to identify specific biomarkers for each affection. The general hypothesis of this work is that intra- and inter RFN connectivity is different between bipolar patients and unipolar patients. Specifically the investigators assume that connectivity within the default mode network (including ventral mediofrontal cortex, subgenual cingulate cortex, inferior parietal cortex, posterior cingulate cortex) will be increased in unipolar patients compared to bipolar patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2011
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 14, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 24, 2017
CompletedFirst Posted
Study publicly available on registry
October 26, 2017
CompletedOctober 31, 2017
October 1, 2017
2.9 years
October 24, 2017
October 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bold signal and connectivity coefficients within and between neural networks
Bold connectivity assessed with resting state fMRI within and between networks
one day (within 16 days after inclusion)
Secondary Outcomes (2)
Correlations between clinical scores (MADRS, YMRS, SCID) and neural network connectivity.
one day (within 16 days after inclusion)
Sensibility and specificity of fMRI to predict unipolar and bipolar depressive status
one day (within 16 days after inclusion)
Study Arms (3)
Bipolar disorder type I or II
ACTIVE COMPARATORa single resting state fMR for patients with bipolar disorder type I or II with acute depressive state
Unipolar disorder
ACTIVE COMPARATORa single resting state fMR for patients with monopolar disorder with acute depressive state
Healthy volunteers
OTHERa single resting state fMRI for subjects without psychiatric disorders assessed by the SCID
Interventions
One single fMRI which is used to characterize a uni or a bipolar major depressive episode (MDE).
Eligibility Criteria
You may qualify if:
- Unipolar and bipolar depressed patients including patients with type I and type II bipolar disorders.
- Patients in an acute depressive state (according to DSM-IV criteria).
- Men or Women with age between 18 to 65 years.
- Patients with unipolar depression must fullfill Mitchel's criteria for unipolar depression.
- MADRS score \> 22
- YMRS score \< 12
- Mean duration of depressive episode \< 1 year
- in-patient or out-patient
- Healthy volunteers matched for age and socio-educational level, without personal history of unipolar or bipolar depression and without psychiatric disorders
You may not qualify if:
- Patients and controls:
- Bipolar disorder with rapid cycling
- Suicidal thoughts with score \> 3 at the MADRS item 'suicide'
- Depression with psychotic features
- Psychiatric co-morbidity including other AXIS-1 disorders (OCD, schizophrenia, social phobia) and borderline personality disorder
- Substance and alcohol abuse or dependance
- Recent treatment with ECT (\< 6 months)
- Previous history of Brain Traumatic Injury; neurological disorders (multiple sclerosis, parkinson's disease, stroke) or disorders associated with abnormal MRI (lupus, Behcet's disease)
- Contra-indication of MRI: pregnancy; tatoos; claustrophobia
- Patient hospitalized under legal condition
- Patient that requires an important sedation due to anxiety
- Bipolar patients that requires at less 3 mood stabilizers
- Patient receiving a new antidepressant since more than 10 days
- Patients without social security insurance
- Patients with legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe FOSSATI, Professor
AP-HP, Pitié-Salpêtrière Hospital of Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2017
First Posted
October 26, 2017
Study Start
December 14, 2011
Primary Completion
November 18, 2014
Study Completion
June 1, 2017
Last Updated
October 31, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share